Fan Pages For Pharmaceuticals?
The Federal Trade Commission is going to hold public hearings on creating regulations so that pharma companies can use social media (ie, Facebook, Twitter, networking sites) to promote their drugs. Like they don’t have enough promotion opportunities already. I’d assume the FDA will also have to get involved in this somehow since drug promotion is also its regulatory bailiwick.
The folks at digidaydaily.com think it’s a lovely idea–I don’t–and have a suggestion:
“Create Fan Pages: It’s in the company’s best interest to supervise and add some credibility to a Seroquel community for bipolar adults, or a Paxil community for depressed patients. If you don’t agree go on Facebook and look at the unsupervised version.”
Whomever wrote this is utterly clueless if he thinks Seroquel and Paxil are drugs that would generate a fan base. More like an anti-fan base. And would pharma companies allow criticism, even the honest kind, on their drugs’ social networks? Probably not. And how would they keep kids under the age of 18 from viewing the pages?
Related posts:
Posted in Furious Seasons